Sign Up to like & get
recommendations!
0
Published in 2024 at "Blood"
DOI: 10.1182/blood-2024-194405
Abstract: Background & aim: Patients (pts) with MDS-del(5q), including those with TP53 multihit mutations, exhibit better outcomes compared to the general MDS population (Montoro et al., Blood 2024). However, approximately 20% of MDS-del(5q) eventually progress to…
read more here.
Keywords:
mds del;
ipss del;
risk;
del ... See more keywords